Srinivas Akkaraju - Sep 4, 2025 Form 4 Insider Report for Mineralys Therapeutics, Inc. (MLYS)

Role
Director
Signature
/s/ Srinivas Akkaraju
Stock symbol
MLYS
Transactions as of
Sep 4, 2025
Transactions value $
$14,999,993
Form type
4
Date filed
9/8/2025, 08:07 PM
Previous filing
Sep 5, 2025
Next filing
Sep 25, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
AKKARAJU SRINIVAS Director 628 MIDDLEFIELD ROAD, PALO ALTO /s/ Srinivas Akkaraju 2025-09-08 0001253170

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MLYS Common Stock Purchase $15M +588K $25.50 588K Sep 4, 2025 By Samsara Opportunity Fund, L.P. F1
holding MLYS Common Stock 5.67M Sep 4, 2025 By Samsara BioCapital, L.P. F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Securities are directly held by Samsara Opportunity Fund, L.P. ("Samsara Opp LP"). Samsara Opportunity Fund GP, LLC ("Samsara Opp GP") is the general partner of Samsara Opp LP and may be deemed to beneficially own the securities held by Samsara Opp LP. The Reporting Person has voting and investment power over the shares held by Samsara Opp LP and, accordingly, may be deemed to beneficially own the shares held by Samsara Opp LP. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein.
F2 Securities are directly held by Samsara BioCapital L.P. ("Samsara LP"). Samsara BioCapital GP, LLC ("Samsara LLC") is the general partner of Samsara LP and may be deemed to beneficially own the securities held by Samsara LP. The Reporting Person has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein.